X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

India & Europe join hands for cancer and neurodegenerative disease remedies

Yuvraj_pawp by Yuvraj_pawp
27th February 2015
in Middle East and South Asia, Projects

Co-ordinated activities in health research between European and Indian research teams just got a major fillip. The Indian Council of Medical Research (ICMR) will soon begin research in the identified areas of cancer and neurodegenerative diseases with the European Union (EU). According to senior officials in the ICMR, the collaborative research between the ICMR and the EU is based on the discussions between the ICMR and the EU at a workshop held in February, 2010 in New Delhi. In the workshop, cancer and neurodegenerative diseases were identified as areas of mutual interest.

Officials said that both the ICMR and the European Commission’s Directorate General for Research and Innovation (DG RTD), Brussels have mutually agreed to enhance opportunities for coordinated activities in health research between European and Indian research teams, wherein it is intended to encourage scientists and health providers in India and EU to work towards the goal for the improvement of health of the people. For collaborative research for the year 2010-11, the priority areas identified by the ICMR and the EU for research include creating clinical and molecular tools for experimental therapy of paediatric neurodegenerative disorders causing childhood dementia in Europe and India; and the epidemiology and aetiology of infection-related cancers.

The ICMR has invited applications from the Indian scientists affiliated with medical/health institutes in India for collaboration under the two specific programmes of neurodegenerative diseases and cancer. Under the neurodegenerative diseases programme, project on a treatment-oriented research project of NCL disorders as a major cause of dementia in childhood has been selected for funding by European Union. Indian scientists can apply on a similar protocol.

The project is expected to contribute to the description of the natural course and the clinical spectrum, prevention, early detection and evaluation of innovative therapies of paediatric neurodegenerative diseases in Europe and India, which might take place through gene and or enzyme-based therapies, early detection and identification of high risk populations. Under the cancer programme, from EU side, one project on role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe has been selected for funding. Indian scientists can also apply on a similar protocol. The results of research in this area should contribute to prevention and early treatment of infection-related cancers in Europe and India, which is likely to be facilitated through vaccination, early detection and identification high-risk populations.

Tags: Middle East & South Asia
Previous Post

GSK's new chairman Hampton to take charge in May

Next Post

Alizé Pharma launches Phase II clinical trial of AZP-531 in Prader-Willi syndrome

Related Posts

ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
CPHI Japan 2024: Rising Tides manufacturing in Japan
Middle East and South Asia

CPHI Japan 2024: Rising Tides manufacturing in Japan

14th March 2024
Danone enters adult medical nutrition category in China
Middle East and South Asia

Danone enters adult medical nutrition category in China

13th January 2024
Middle East and South Asia

Technology And Policy To Drive Biopharma And Medtech Growth

12th July 2023
US - China Trade In Pharmaceuticals Soars In Recent Years
Middle East and South Asia

US – China Trade In Pharmaceuticals Soars In Recent Years

7th July 2023
Assessing Q1 2023: Indian Pharma Industry Growing Rapidly
Insights

Assessing Q1 2023: Indian Pharma Industry Growing Rapidly

28th June 2023
Next Post

Alizé Pharma launches Phase II clinical trial of AZP-531 in Prader-Willi syndrome

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In